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CHAPTER I 
INTRODUCTION 
Tobacco in all of its various forms has an elaborate history 
dating back to its early beginnings nearly five centuries ago. Most of 
the tobacco used worldwide is smoked. Recently, the practice of 
chewing tobacco has emerged as a popular habit in the United States. 
"Snuff dipping" is currently a popular manner of tobacco use in this 
country (Rohrer and Young, 1982). 
Smokeless tobacco refers to tobacco which is designed to be chewed 
or sniffed rather than smoked. Dipping is the process of placing a 
pinch of tobacco (snuff) between the lower lip and teeth, where it 
stimulates the flow of saliva and mixes with it (American Cancer 
Society, 1981). 
Smokeless tobacco is currently being heavily promoted through mass 
media advertising using well-known sports figures and entertainers to 
act as spokespersons. The sales of smokeless tobacco have increased 
about 11% each year since 1974, with an estimated 22 million users in 
the United States (Christen, 1980). Recent surveys have shown that 
many males in elementary schools, high schools, and colleges are 
adopting these habits. In one study of Texan collegiate athletes, up to 
one third of the varsity football and baseball team members were using 
some form of smokeless tobacco (Christen et al., 1979). Marty and 
associates (1985) reported that 15 to 20% of high school pupils in some 
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parts of the United States regularly use smokeless tobacco. In a survey 
conducted in Arkansas, it was reported that 18.9% of the total 
population used smokeless tobacco, with the majority of users being 
males (Marty et al., 1985). Winn and associates (1981) reported that 
smokeless tobacco use among women in the southeastern United States 
represented a substantial risk for the development of oral and 
pharyngeal cancer. In a recent study in Oklahoma it was reported that 
13% of third grade males regularly use smokeless tobacco (Glover and 
Edwards, 1985). 
Researchers disagree on the possible harmful effects of smokeless 
tobacco use. Russell and co-workers (1980) have suggested that 
smokeless tobacco may be a less harmful substitute for cigarette 
smoking. Other researchers elucidate the incidence of oral cancers 
with smokeless tobacco use (Christen et al., 1979; Waldron and Shafer, 
1974; World Health Organization, 1978). 
Reasons for smokeless tobacco use vary considerably, ranging from 
sociability to psychological and physiological effects obtained. Many 
athletes who use smokeless tobacco while performing claim that it 
improves their reaction time, heightens their ability to concentrate 
for extended periods of time, and generally improves their overall 
performance (Glover et al., 1984). Additionally, some football and 
baseball players claim that smokeless tobacco use keeps their mouths 
from drying out excessively while they are engaged in their sport 
(Christen, 1980). 
Regardless of the varied reasons attributed to why smokeless 
tobacco is used, there appears to be a void in the literature related 
to the electrophysiological effects of smokeless tobacco. 
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Electrophysiological studies involve the study of the chemical and 
electrical mechanisms that occur in biological organisms. Studies 
measuring reaction time would be an example of this type of research. 
Reaction time is defined as the period of time that elapses 
between the presentation of a stimulus to the initiation of a response 
(Sage, 1971). Reaction time can be further broken down into four 
components: sense organ time, brain time, nerve time, and muscle time 
(Drowatzky, 1975). Nerve and muscle time can be measured through the 
use of electromyography and nerve conduction instrumentation. Nerve 
time involves the time period that is necessary for the electrical 
impulse to transverse the length of a nerve. Motor nerve conduction 
velocity measurements involve stimulating a nerve at one point and 
recording the response either at the muscle or at some distance along 
the nerve (Goodgold and Eberstein, 1972). Motor nerve distal latency 
measurements consist of stimulating a nerve near its terminal end and 
are usually expressed in time values indicating when a response is 
observed. The units of this measurement are usually expressed in 
milliseconds. These units are used to indicate the importance of the 
residual latency values that are obtained in this region of the nerve. 
The nerve conduction velocity is considerably slower in this region of 
the nerve and is attributed to two major factors: 1) the decreasing 
size of the nerve fiber, and 2) a delay in conduction at the 
neuromuscular junction (Johnson, 1980). 
A limited number of research studies on smokeless tobacco exist in 
the professional literature, due probably to the relative obscurity of 
smokeless tobacco in the past century. Most of the research that has 
measured the electrophysiological effects of tobacco in humans has 
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been obtained in cigarette smoking studies. However. with the recent 
mass marketing techniques of the manufacturers, the increasing use of 
smokeless tobacco products, and the controversies involving smokeless 
tobacco use. further research is needed to determine the full effects 
of smokeless tobacco use. 
Statement of the Problem 
The purpose of this study was to compare the median nerve motor 
distal latency differences in a group of subjects who regular used 
smokeless tobacco, before and after ingesting smokeless tobacco in two 
different dosages and a placebo chewing gum. 
Significance of the Study 
This study is significant in that it will contribute to the body 
of knowledge regarding the electrophysiological effects of smokeless 
tobacco. This study could also make a contribution to the health 
education community, both in the private and public sectors. It is 
further hoped that the results of this investigation will provide 
students, athletes, coaches, and educators with additional knowledge 
concerning smokeless tobacco use so that they may make more informed 
decisions concerning its use. 
Hypotheses 
The hypotheses that were tested in this research were for the 
purpose of investigating the differences between the median nerve 
pretreatment motor distal latency values and the 15 posttreatment 
4 
motor distal latency values of smokeless tobacco users during three 
different treatment conditions. The following null hypothesis were 
tested at the .05 level of significance: 
1. There is no significant difference between the pretreatment 
median nerve motor distal latentices and the 15 posttreatment median 
nerve motor distal latencies of those subjects who ingest the placebo 
chewing gum. 
2. There is no significant difference between the pretreatment 
median nerve motor distal latencies and the 15 posttreatment median 
nerve motor distal latencies of those subjects who ingest one pouch of 
"Skoal Bandits" smokeless tobacco. 
3. There is no significant difference between the pretreatment 
median nerve motor distal latencies and the 15 posttreatment median 
nerve motor distal latencies of those subjects who ingest their regular 
smokeless tobacco dip. 
4. There are no significant differences in the 15 posttreatment 
median nerve motor distal latencies of the subjects after receiving 
each of the three treatment conditions. 
Limitations of the Study 
This investigation was limited in the following ways: 
1. The results and conclusions are limited to the population of 
college-aged students having similar characteristics as the sample that 
was utilized in the study. 
2. No attempt was made to control interest or motivation of the 
subjects. Participation in the study was on a voluntary basis. 
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Delimitations of the Study 
The study was restricted in the following ways: 
1. Only male subjects participated in the study. 
2. Subjects who exhibited an abnormally long (greater than 4.5 
milliseconds) median nerve motor distal latency value in their pre-
treatment test were eliminated from the study. This could indicate 
some type of median nerve pathological condition. 
Assumptions of the Study 
In the investigation, the following assumptions were made: 
1. It was assumed that there was no significant differences in 
the diurnal variations of the distal latencies of the subjects. 
2. The order of treatments received by the subjects was 
counterbalanced, so it was assumed that no treatment order effects 
existed. 
3. It was assumed that the standardized smokeless tobacco dose 
("Skoal Bandits") represented a smaller dose of nicotine than the 
subject's regular tobacco dip. 
4. It was assumed that the subjects refrained from any tobacco 
use and strenuous physical activity during the two hour time period 
prior to each of the testing periods. 
Definitions of Terms 
Acetylcholine. "A neurotransmitter at the myoneural junction'' 
(Kruk and Pycock, 1979, p. 22). 
Agonist. "A drug that interacts with a receptor to produce 
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the normal physiological effect" (Leavitt, 1982, p. 25). 
Anastomosis. "An end-to-end union, joining together, or 
intercommunication of parts of any network or set of fibers such as 
nerves" (Thomas, 1973, p. A-73). 
Antagonist/Blocker. "A drug which acts upon receptors and 
blocks the normal physiological process" (Leavitt, 1982, p. 26). 
Axon. A process of a neuron that typically conducts nerve 
impulses away from the cell body; however. axons can transmit impulses 
in either direction (Sage, 1971, p. 32). 
Buccal Mucosa. The surface (innermost) layer of tissue of the 
mouth in the region of the cheek and gum (Wilson and Wilson, 1983, 
P• 311). 
Cholinergic Nerve. "Nerves that release acetylcholine at 
their terminal endings" (Levitt. 1981, p. 65). 
"Copenhagen". Snuff produced by the United States Tobacco 
Company (Nashville. TN 37203). 
Drug Affinity. "A measure of the attraction of a drug for 
it's target site" (Kruk and Pycock. 1979, p. 17). 
Electromxography. The process of recording the electrical 
activity that is occurring in a muscle by placing elect~odes over the 
muscle (deVries, 1980 1 p. 61). 
Hertz. Cycles per second. 
Ion. "An atom or group of atoms bearing a negative or 
positive electric charge" (Scott. 1975, p. 34). 
Median Nerve. "A nerve in the arm that sends a motor branch 
to the superficial head of the flexor pollicis brevis 1 the abductor 
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pollicis brevis,and opponens pollicis muscles of the thumb" (Johnson, 
1980, p. 31). 
Motor Nerve Distal Latency. The period of time required for 
an electrical signal to travel down the terminal branch of a nerve 
(Johnson, 1980, p. 20). In this study, it involved the median nerve 
and a measured distance of 7 centimeters. 
Myelin. "A fatlike substance forming the principal component 
of the myelin sheath of nerve fibers" (Thomas, 1973. p. M-77). 
Neuromuscular (Myoneural) Junction. The point where a nerve 
joins a muscle whose function is to "· •• transfer impulses from the 
very small motor nerve endings to the much larger muscle fibers" 
(MacLean, 1980, p. 73). 
Neurotransmitter. "A chemical that transmits neural 
information across a synapse" (Levitt, 1981, p. 58). 
Nictoine. "The major chemical compound present in tobacco 
products that is generally agreed to be responsible for the 
behavioral use of tobacco products" (Dunn, 1978. p. 19). 
Nicotinic Receptor. "A receptor in which nicotine can mimic 
the effects of acetylcholine" (Levitt, 1981, p. 68). 
Receptor. "A highly specific glycoprotein cell component on 
a postsynaptic membrane" (Leavitt, 1982. p. 25). 
"Regular Skoal". Wintergreen flavored powdered tobacco 
produced by the United States Tobacco Company (Nashville, TN 37203). 
"Skoal Bandits". Small, teabag-like pouches of wintergreen 
flavored tobacco produced by the United States Tobacco Company 
(Nashville, TN 37203). 
Smokeless Tobacco. "Tobacco that is designed to be chewed or 
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sniffed rather than smoked" (Glover et al., 1984, p. 22). 
Snuff. Finely ground (powdered) tobacco. 
Snuff Dipping. "The process of placing a pinch of powdered 
tobacco between the cheek and gum" (Glover, Christen, and Henderson, 
1982, p. 2). 
Sweep. The horizontal (x-axis) linear time axis of a cathode 
ray tube display generated by the left-to-right movement of the trace 
spot at constant preselected speeds across the face of the cathode 
ray tube display (Johnson, 1980, p. 433). 
Synapse. "The gap between a nerve terminal and another 
tissue" (Kruk and Pycock, 1979, p. 10). 
TECA TE42. The electromyography and nerve conduction 
instrumentation used in this study (Teca Corporation, Three Campus 
Drive, Pleasantville, New York 10570). 
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CHAPTER II 
REVIEW OF THE LITERATURE 
Literature Related to the Problem 
Investigators planning to conduct research studies that involve 
the electrophysiological effects of tobacco and nicotine should be 
knowledgeable about the various actions of nicotine on the particular 
biological system concerned. It is essential that certain 
understandings about the nervous system be acquired. Similarly, it is 
important to recognize and understand the characteristic actions of 
nicotine on the nervous system. In addition, it is essential that the 
investigator develops a thorough background in the instrumentation that 
is required for the collection of the information needed in these types 
of studies. The researcher must become competent in the procedures 
and techniques required in order that accurate measurements can be 
obtained. 
It is, therefore, requisite that the literature review should 
address all of these issues which will be associated with the findings 
so that accurate interpretation of the results is possible. The first 
section of this chapter addresses the electrophysiological 
characteristics of the nervous system, particularly the neuromuscular 
junction. A second portion deals with the characteristics of tobacco 
and nicotine, and reviews the existing literature in smoking and 
lD 
smokeless tobacco studies. A third section concerns the 
instrumentation, data collection, and data handling procedures and 
methodologies. 
Electrophysiological Characteristics 
of Neural Transmission 
The human nervous system is often anatomically divided into two 
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major systems: the central nervous system, which consists of the brain 
and spinal cord, and the peripheral nervous system, which includes 12 
pairs of cranial and 31 pairs of spinal nerves, in addition to the 
peripheral parts of the autonomic nervous system (Sage, 1971). It is 
also commonly divided into two divisions according to the functions 
performed: the voluntary and involuntary nervous systems. The portion 
that supplies the skeletal muscles used in movement is called the 
voluntary, or somatic, nervous system. The portion that supplies the 
internal organs and associated structures is known as the involuntary, 
or visceral, nervous system (Levitt, 1981). The reader should also 
realize that there are overlaps within these functional 
classifications. 
The structural and functional unit of the nervous system is the 
neuron. In general, nerve fibers are classified into afferent or 
efferent fibers. Afferent fibers conduct impulses toward the central 
nervous system and are referred to as sensory neurons. Efferent fibers 
conduct impulses away from the central nervous system and are called 
motor neurons (Sage, 1971). Normally a nerve fiber transmits impulses 
in only one direction. For motor nerves, this is towards the muscles. 
However, nerve fibers are also able to conduct impulses in the 
direction opposite to what occurs normally, but the functional 
characteristics at the synapses generally allow signal transmission to 
occur in only one direction (Ottoson, 1983). 
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A nerve is a collection, or bundle, of nerve fibers bound together 
by a connective tissue sheath. Nearly all nerves are mixed nerves, 
which indicates that they contain both afferent and efferent fibers 
(Sage, 1971). 
The function of the neuron is to carry nerve impulses. The nerve 
impulse can be thought of as an electric current being conducted (Sage, 
1971). This current is the result of changing concentrations of ions 
inside and outside of the nerve cell membrane. The polarity of the 
nerve axon is maintained by a differential balance of ions on the 
inside and outside of the membrane. When a neuron is at rest, the 
cytoplasm inside the axon contains a large number of protein molecules 
along with some chloride ions, and a low concentration of sodium ions. 
The combined charge on the inside of the membrane is negative. The 
tissue fluid bathing the outside of the membrane is rich in sodium, 
having a sodium concentration size of approximately ten times greater 
than that existing on the inside of the axon. The resulting charge 
outside the membrane is positive. The membrane voltage has been 
measured between -70 and -90 mV, and produces a strong pressure for an 
inflow of the sodium ions. However, the resting membrane is 
impermeable to sodium ions, effectively blocking the flow (Sage, 1971). 
When the neuron is stimulated to a sufficient degree, the membrane 
suddenly becomes permeable to sodium, which enters the axon at a rapid 
rate. This influx of sodium ions reverses the internal potential of 
the membrane from about -70 mV to +40 mV. The outside of the 
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membrane becomes negative in relation to the inside. This process 
ignites the nerve impulse (Sage, 1971). The membrane potential then 
immediately returns to its resting value. This sequence of potential 
changes is called the action potential (Schriber, 1975). This action 
potential propagates, section by section, along the whole length of the 
axon until it reaches its terminal ends (Figure 1). The nerve endings 
of the axon interface with other neurons or other cells, such as a 
muscle fiber. The junction of one neuron to another is called a 
synapse (Bickerton and Small, 1982). A synapse represents a structural 
discontinuity in the system and is characterized by special 
properties. The connection is not a physical one as there exists a 
physical gap, called the synaptic gap or cleft, that separates the two 
connections. It is at the synapses that the action potential is 
transmitted chemically to the next element in the neural sequence 
(Levitt, 1981). The chemical synapse has been described as a ''one-way 
valve," since it allows transmission in only one direction (Ottoson, 
1983). There is also a delay in the transmission at the synapse that 
is attributed to the chemical processes involved (Ottoson, 1983). 
The action potential results in changes in the presynaptic 
membrane of the axon. These changes initiate the release of a chemical 
from the neuron into the synaptic cleft. Release of chemicals in 
response to activation of a nerve is termed neurochemical 
transmission. The chemical that is released is called a neuro-
transmitter, since the chemical transmits neural information (Kruk 
and Pycock, 1979). This neurotransmitter then diffuses across the 
synaptic cleft and binds with receptor molecules in the postsynaptic 
membrane. Receptors are discrete regions of the postsynaptic membranes 
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(A) 
(B) 
(C) 
Source: George H. Sage, Introduction to Motor Behavior: A Neuro-
psychological Approach (1971)-.-
Figure 1. Propagation of an Action Potential in a Neuron. 
The arrows show the direction of transmission 
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which selectively bind molecules of a specific structure (Kruk and 
Pycock, 1979). The interaction of a neurotransmitter with its receptor 
initiates a response within the postsynaptic structure (Levitt, 1981). 
There is some question as to the exact nature of the receptor 
activation process. The occupation theory suggests that the response 
is initiated by the process of occupation of a receptor, whereas the 
rate theory hypothesizes that the response is initiated by the 
whole process of linking onto and the detachment from the receptor 
(Kruk and Pycock, 1979). Regardless of which theory is valid, the 
combination of neurotransmitter with its receptor must be quickly 
reversed between each impulse, leaving the receptor free to combine 
with the next packet of neurotransmitter produced (Ashton and Stepney, 
1982). Following release, a neurotransmitter would continue to 
stimulate receptors if mechanisms for terminating its action did not 
exist. Enzymatic inactivation and neuronal re-uptake are the two 
major mechanisms that have been identified (Kruk and Pycock, 1979). 
Nerves are generally classified according to the neurotransmitter 
that they release. Those that release acetylcholine are called 
cholinergic fibers (Levitt, 1981). Acetylcholine was the first 
chemical to be identified and proven as a neurotransmitter. 
Acetylcholine is synthesized and then stored in the end terminals of 
the neuron in subcellular structures called vesicles. It is a widely 
held view that the acetylcholine stored within the vesicles is 
released in a quantal manner in response to an action potential 
arriving at the nerve terminal (Kruk and Pycock, 1979). Kruk and 
Pycock (1979) also suggest that this hypothesis is tentative. It has 
also been discovered that approximately half of the acetylcholine 
content of the nerve terminal is floating freely in the cytoplasm of 
the terminal (Dunant and Israel, 1985). Recently, Dunant and Israel 
(1985) found, in their studies of the electric fish Torpedo, that the 
source of acetylcholine emitted by a neuron is the cytoplasm rather 
than the synaptic vesicles. 
Motor nerve fibers and their endings are known to contain 
acetylcholine and the enzymes needed to synthesize it. The 
postsynaptic membrane area also contains the enzyme, 
acetylcholinesterase, which breaks down acetylcholine through 
hydrolysis (Katz, 1966). 
Two major categories of cholinergic receptors have been formed 
based on the actions of two drugs of plant origin which were found to 
mimic the effects of stimulating specific nerves: muscarine and 
nicotinic receptors. Most cholinergic receptors in the nervous system 
and at the neuromuscular junction are nicotinic receptors. Nicotinic 
receptors show different sensitivities to agonists and receptor 
blockers, which seems to indicate that more than one type of 
nicotinic receptor may exist (Kruk and Pycock, 1979). 
Neuromuscular Junction 
The point at which motor neurons interface with muscle fibers is 
called the neuromuscular, or myoneural, junction. This is the site at 
which information is transformed from an electrochemical impulse along 
the neuron into the mechanical contraction of a muscle fiber (Levitt, 
1981). A motor unit is composed of a motor neuron and all the muscle 
fibers that the neuron innervates (MacLean, 1980). 
The structure of the junctional apparatus includes a nerve 
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terminal (presynaptic membrane), a motor endplate (postsynaptic 
membrane), and a synaptic cleft that separates the two (Figure 2). The 
motor endplate is a structural enlargement of the muscle fiber that 
forms a trough, into which fits the terminal nerve ending. The 
endplate has many infoldings resembling little mounds and gutters that 
are continuous with the muscle sarcolemma. Because of these many 
infoldings, the motor endplate has a much larger surface area than 
the nerve terminal it envelops (MacLean, 1980). 
The nerve terminal is an unmyelinated extension of the axon and is 
rich in mitochondria and numerous spherical synaptic vesicles which 
contain acetylcholine. The postsynaptic membrane contains highly 
specialized protein receptor molecules that recognize and bind the 
acetylcholine (Ottoson, 1983). The synaptic cleft between the two 
membranes is approximately 20 nanometers (Korenyi-Both, 1983). This 
synaptic cleft is too wide to allow the currents underlying the nerve 
impulse to generate impulses in the muscle fibers electrically. Since 
the diameters of the nerve terminals are much smaller than the 
connecting muscle fibers, the current produced by the nerve terminal 
would be insufficient to initiate impulses in the underlying muscle 
membrane. A delay of 0.5 to 0.8 milliseconds occurs between the 
arrival of a nerve impulse and the onset of a muscle action potential 
and is inconsistent with the assumption of electrical transmission 
(Ottoson. 1983). 
The neurotransmitter role of acetylcholine has been known since 
the mid 1920s and has been well established as the neurotransmitter at 
the neuromuscular junction (Levitt, 1981). Acetylcholine is 
synthesized chiefly in the motor nerve terminals and floats 
PRESYNAPTIC 
MEMBRANE 
SYNAPTIC 
VESICLES 
NICOTINIC 
RECEPTOR 
TERMINAL 
NERVE ENDING 
POSTSYNAPTIC 
MEMBRANE 
Source: Ian C. Maclean, "Neuromuscular Junction", Ernest W. Johnson 
(ed.), Practical Electromyography (1980). 
Figure 2. The Neuromuscular Junction 
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freely within the cell cytoplasm as well as being stored within the 
synaptic vesicles. Spontaneous release of acetylcholine occurs in both 
quantal and nonquantal forms. The release of one or a few quanta gives 
rise to depolarizations of small amplitudes called miniature endplate 
potentials, or mepps, that remain localized to the region of the 
endplate. Conducted nerve impulses result in the release of large 
numbers of acetylcholine quanta which generate large endplate 
potentials, or epps, which trigger a complex sequence of events which 
initiates muscle contraction (Drachman, Pestronk, and Stanley, 1982). 
A description of the major events that summarizes how the neural 
impulse is transmitted from the motor nerve to the muscle fiber is 
given by Ottoson (1983) below: 
When the nerve terminals are invaded by an impulse, 
calcium ions enter the endings and become attached, probably 
to the membranes of the vesicles. This appears to induce 
the vesicular membrane to fuse with the plasma membrane of 
the terminal. Finally, the fused membranes rupture and the 
acetylcholine content of the vesicles is emptied into the 
synaptic cleft. The acetylcholine so released diffuses 
through the cleft and reacts with specific glycoprotein 
receptors in the endplate membrane. Under the influence 
of acetylcholine, the receptor molecules change their 
conformation, and the channels which admit both sodium 
and potassium open. This results in a depolarization of 
the endplate and the generation of the endplate potential, 
which has all the characteristics of a local signal; by 
depolarizing adjacent regions of the muscle membrane, the 
endplate potential initiates the action potential of the 
muscle fiber, which travels from the endplate and induces 
the contractile response of the muscle fiber (p. 116). 
Acetylcholine released at the neuromuscular junction acts 
postsynaptically on nicotinic receptors (Kruk and Pycock, 1979). 
The acetylcholine-receptor combination is broken down rapidly, within 
an interval of approximately one millisecond. This process must occur 
rapidly, otherwise the endplate would not be able to respond to motor 
impulses arriving in close succession. A characteristic feature of 
peripheral nerves is that they are able to conduct impulses for a 
considerable time without becoming fatigued (Ottoson, 1983). Failure 
of a muscle fiber to generate an action potential could be attributed 
to either an inadequate release of acetylcholine or a decreased 
receptivity of the muscle fiber membrane (Levitt, 1981). 
Anything that interferes with the interaction between 
acetylcholine and its receptors will block neuromuscular transmission. 
A number of different substances have been identified that will block 
neural transmission in the neuromuscular junction by binding with the 
acetylcholine-nicotinic receptor molecules, thus preventing the normal 
acetylcholine-receptor combination. Some known blockers include 
curare, tubocurarine, polymyoxin, neomycin, streptomycin, and 
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kanamycin (Gilroy and Meyer, 1975; Katz, 1966; Kruk and Pycock, 1979; 
and Ottoson, 1983). Other drugs can have various effects at the 
neuromuscular junction using different mechanisms of action. Botulinum 
toxin prevents acetylcholine from being released from all cholinergic 
nerves. Black Widow spider venom is thought to cause an explosive 
release of acetylcholine from the cholinergic nerve fibers (Kruk and 
Pycock, 1979). 
The synapse and the neuromuscular junction are very sensitive to 
asphyxia and ischemia, along with being very susceptible to a variety 
of drugs, such as those ment].oned above. In general, the more synapses 
involved, the more susceptible is the transmission process to the 
influence of drug factors (Ottoson, 1983). 
Literature Related to Tobacco 
A vast amount of literature exists on tobacco use. Kozlowski 
(1984) reports an amusing Arabian story written by Bain in 1896 
relating the mythical origin of tobacco and its continued use: 
••• the Prophet, Mahomet, rescued a snake from freezing by 
warming the snake against his body. The thankless snake 
bit him, but Mahomet sucked the venom from his wound and 
spat it upon the ground. On that spot, it was said, grew 
the first tobacco plant, combining the compassion of the 
prophet with the venom of the serpent (pages 311-312). 
Kozlowski (1984) further states that 
The quest for less hazardous tobacco products has been 
directed toward reducing or eliminating the 'venom' of 
tobacco, while at the same time keeping its 
'compassion' (p. 312). 
Tobacco has been used for nearly 500 years in various forms. 
American Indians were apparently the first to use tobacco in all its 
various forms, which included smoking, chewing, and sniffing it 
through their nostrils (Christen et al., 1982). Tobacco apparently 
provides the user with both beneficial and adverse effects. Tobacco 
has been found to be physiologically and psychologically arousing, may 
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enhance certain aspects of learning and memory, and may also serve as a 
relaxant. Some common acute adverse effects of tobacco include 
nausea, vomiting, and dizziness. The chronic use of tobacco is 
probably the more serious problem. The user can develop a tolerance to 
tobacco. There are also withdrawal symptoms associated with tobacco 
discontinuance, however, these are mild and never life-threatening. 
Some of these symptoms may include drowsiness, nervousness, anxiety, 
headaches, and energy loss (Leavitt, 1982). Leavitt (1982) also notes 
that the tobacco habit may be the hardest of all drug habits to kick. 
Russell and co-workers (1980) observed that tobacco has been used in 
its various forms for four centuries, but noted that no population has 
been able to give up one form of tobacco without replacing it with 
another. They further indicated that the common factor is nicotine 
(Russell et al., 1980). 
Nicotine 
There have been many chemicals identified in cigarette smoke, but 
there is general agreement among researchers that nicotine is the 
pharmacological agent of prime importance accounting for tobacco use 
(Ashton and Stepney, 1982). Tobacco is the only natural source of 
nicotine (Russell et al., 1980). Nelson (1978) observes that nicotine 
has been described as a psychoactive agent possessing many different 
properties including tranquilizing, antianxiety. stimulating, 
depressing, anti-aggressive, mood-stabilizing, and stress-attenuating 
effects. 
Nicotine is used primarily in individual and social settings and 
is placed in the classification of social drugs by Leavitt (1982). 
Nicotine is colorless, volatile. strongly alkaline, and considered a 
very powerful drug. Two or three drops of nicotine placed on the 
tongue would rapidly kill an adult, and the nicotine content of about 
60 milligrams, that contained in one cigar, would be fatal to a human 
if injected intravenously (Russell, 1976). In fact, nicotine is found 
in some insecticides (Kruk and Pycock, 1979). 
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At the 7.4 pH level of the blood and at normal body temperature 
of 37° C., over 30% of the nicotine molecule exists in an un-ionized 
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free form, which is extremely lipid soluble (Ashton and Stepney, 1982). 
The rate of absorption of free form nicotine is dependent on pH. At 
an acid pH very little nicotine is absorbed; however, as the pH 
becomes more basic, the amount of nicotine that is absorbed increases 
(Russell, 1976). Armitage and colleagues (1970) have shown that buccal 
absorption of nicotine is also pH-dependent. It appears that nicotine 
is actively secreted by the salivary glands. It is interesting to 
note that the pH of saliva shows a diurnal variation and ranges from 
5.6 to 7.6. It increases very slightly after smoking and also changes 
before, during, and just after a meal. Depending upon the buccal 
fluctuations, some of the salivary nicotine would be reabsorbed 
through the buccal mucosa (Russell, 1976). 
One of the intportant factors that influences the absorption 
rate of nicotine is the blood flow through the tissues at the site of 
administration (Leavitt, 1982). Once taken up into the blood flowing 
through the administration site, the nicotine is pumped rapidly to all 
parts of the body. The nicotine may reach the brain in about 7 seconds 
and the big toe in 15 to 20 seconds (Ashton and Stepney, 1982). 
Stalhandske (1970) showed that intravenously injected nicotine is 
immediately taken up in the brain of mice, reaching a maximum 
concentration within one minute after injection; however, by 60 
minutes the concentration had fallen to within 1% of the maximum level 
attained. Studies with many species of animals including mice, cats, 
dogs, and monkeys have shown that nicotine is taken up quickly by the 
brain and other nervous tissues (Ashton and Stepney, 1982). Ashton, 
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Thompson, and Marsh (1981) note that most of the actions of nicotine 
are exerted on the nervous tissues. The major reasons for this 
preferential uptake of nicotine by the nervous system are probably the 
result of its high lipid content, along with its abundant blood flow. 
However, the high lipid solubility of free nicotine and constant stream 
of blood through these tissues means that the nicotine can diffuse out 
of the tissue readily and be carried away. The speed of exit of 
nicotine from the brain is almost as dramatic as its speed of entry 
(Ashton and Stepney, 1982). 
Nicotine is one of the shortest acting of the common psychoactive 
drugs. It is destroyed rapidly in the liver. After repeated does, 
about half of the nicotine in the blood is metabolized with 80 to 100 
minutes (Gerstein and Levison, 1982). Russell (1976) reported that the 
plasma half-life of nicotine is less than 30 minutes. As indicated 
above, the metabolism of nicotine is relatively rapid. The chief organ 
of metabolism is the liver; however, some metabolism does occur in 
other organs, including the lung, but not the brain. When nicotine is 
absorbed via the stomach into the portal system, most of the nicotine, 
in its first passage through the liver, is metabolized into cotinine 
and nicotine-N-oxide, which are pharmacologically inert substances. 
When absorption occurs through the lungs or nasal and buccal mucosae, 
the liver is bypassed, allowing the nicotine to get to the brain and 
other parts of the body in the active form (Russell, 1976). 
Nicotine is also present in sweat and saliva, but the urine is by 
far the major avenue of excretion from the body of nicotine and its 
metabolites (Russell, 1976). Schachter and coworkers (1977) observed 
that nicotine is excreted more slowly when the urine is alkaline. The 
rate at which nicotine is excreted is thus pH-dependent. Drugs that 
are basic are excreted fastest when the urine is acidic, whereas 
acidic drugs are excreted fastest when the urine is alkaline. Eating 
is another factor that affects urinary pH. The urine becomes more 
acidic about 30 minutes after eating. and then grows more alkaline 
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and remains so for several hours (Leavitt. 1982). It is interesting to 
note that many users tend to use tobacco just after a meal. 
Nicotine produces physiological effects similar to those of 
sympathetic stimulation including increased heart rate, blood pressure, 
metabolic rate, and the secretion of epinephrine (Leavitt, 1982). 
Nicotine has been found to help rats learn more rapidly and affects 
memory. This facilitation of learning and conditioning illustrates the 
dual actions of nicotine, which stimulates and arouses, or sedates and 
relaxes. The response appears to be dependent on dose and individual 
constitution as well as on mood and situation. In general, smaller 
doses improve performance, while larger doses impair performance. 
These responses may be attributable to two tranquilizing effects of 
nicotine, namely, 1) a relaxing effect on skeletal muscle, and 2) 
an increase in the rate of habituation to unimportant stimuli 
(Russell, 1976). 
It is in the nervous system. specifically at the synapses and 
the neuromuscular junction, where the effects of nicotine are unique. 
The nicotine molecule is structurally very similar to the 
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acetylcholine molecule (Figure 3). Ashton and Stepney (1982) note 
that 
One way in which the aceytylcholine receptor recognizes 
its key, the acetylcholine molecule, is by the position of 
two electrical charges, one positive and one negative, 
located at certain sites on the molecule. The distance 
between these two charges is always the same and corresponds 
with two equally spaced and oppositely charged sites on the 
receptor. In the nicotine molecule, the positive charge on 
the ammonium head and the negative charge on the pyridine 
ring are just the same distance apart as they are on the 
acetylcholine molecule. This structural similarity makes 
nicotine a perfect skeleton key to interact with the 
acetylcholine receptors (p. 37). 
Several studies have shown that nicotine mimicks the effects of 
acetylcholine at the myoneural junction (Horrobin, 1968; Kruk and 
Pycock, 1979; Remond, 1979). In effect, nicotine can also initiate 
muscular contraction. However, nicotine has been found to have a 
biphasic effect at the myoneural junction; that is, the initial 
combination of nicotine with the muscle receptor causes a predominantly 
excitatory effect followed by a predominantly inhibitory effect. 
However, the receptor molecule appears to possess an equal affinity for 
the nicotine and acetylcholine molecules. The nicotine combination 
with the muscle receptor is more enduring than the acetylcholine-muscle 
receptor combination, thereby effectively blocking any further 
muscular response. These biphasic effects depend both upon the 
amount of nicotine present and the time interval between nerve 
impulses generated at the synapse (Ashton and Stepney, 1982). In 
summary, much of the complexity and paradox of the effects of nicotine 
appear to be a result of the biphasic action at the cholinoceptive 
sites where nicotine is an agonist, then a blocker of acetylcholine 
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Source: Heather Ashton and Rob Stepney, Smoking--Psychology and 
Pharmacology (1982). 
Figure 3. The structure of nicotine and acetylcholine 
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(Russell, 1976). 
From the previous studies, it is obvious that the actions of 
nicotine are complex. It is clear that there is a mixture of 
stimulant and depressant properties of nicotine at a variety of 
levels that involve the central and peripheral nervous systems. 
Domino (1979) points out that much more research is needed in these 
areas, and further notes that an important area that needs to be 
observed in explaining tobacco use behavior is in the subsequent, 
secondary relaxant effect of nicotine following the initial 
excitatory effect. 
Smoking Studies. Most of the research which exists on 
tobacco has been obtained by studies involving smoking tobacco. Much 
of the information has been obtained in both animal and human studies. 
After reviewing many studies, Ashton and Stepney (1982) feel that 
nicotine and smoking in humans can, in certain circumstances 
••• facilitate performance. increase or decrease arousal, 
and combat the disruptive effects of aggression and stress 
on behavior (p. 116). 
Russell (1976) notes that the experimental data seems to support 
the subjective experience of smokers that it helps them to think, 
concentrate, and cope with stresses. He further indicates that these 
appear to be acquired symptoms of dependence, rather than primarily 
rewarding effects. Nicotine has been found to reduce aggressiveness 
in rats, and smoking may also improve the memorization of new material 
(Russell, 1976). The effects of nicotine are not the same in all 
individuals, but seem to be influenced by the mental and physical 
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makeup of the smoker (Stepney and Pycock, 1982). Stepney (1979) 
suggests that smoking tends to normalize the smoker's state of arousal 
by decreasing it under stress and increasing it during boredom. He 
goes on to say that smoking enhances performance on tasks that 
require vigilance and attention by reducing the disruptive effects 
of anxiety and aggression on performance and behavior. 
2Y 
Dunn and associates (in Battig, 1978) reported that in a contrived 
situation to produce anger, the incited anger was less disruptive of 
task performance in the smoker than in the nonsmoker and the deprived 
smoker. They go on to suggest that perhaps smoking provides a coping 
ability from the disruptive effects of excessive arousal. Schachter 
(1973) reported similar results using an arousal state produced by 
increasing levels of pain (electric shock) and found the ongoing 
behavior less disrupted in smokers than in nonsmokers. Another study 
in which smoking made the disruptions less intrusive was reported by 
Friedman and coworkers (1974) in which habituation to a stimulus 
(loud, brief bursts of sound presented at random intervals) was more 
rapid when subjects were smoking than when not smoking. 
Nicotine is primarily absorbed through the lungs in cigarette 
smoking. Russell and coworkers (1980) observed that it takes the 
smoker about 10 minutes to reach peak levels of nicotine in the 
circulating blood. The cardiovascular effects of smoking are 
predominantly stimulant, causing an increase in heart rate, blood 
pressure, and the basal metabolic rate. The effect of smoking on the 
heart rate and blood pressure can last for as long as an hour. 
Smoking tobacco cigarettes has also been found to cause a drop in 
skin temperature (Russell, 1976). Stepney and Ashton (1982) report 
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an increase in the efficiency of nicotine metabolism in smokers; that 
is, smokers metabolize nicotine more quickly than nonsmokers. This 
increased nicotine tolerance develops in a relatively short period of 
time after nicotine use (Ashton and Stephney, 1982). The nicotine 
levels attained in smoking are degraded in the manner previously 
discussed on nicotine metabolism. It may be important to note that 
the conversion of nicotine to one of its chief metabolites, cotinine, 
is inhibited by the presence of one of the products of cigarette smoke, 
carbon monoxide (Russell, 1976). This may have some significance in 
the process of cigarette smoking. 
Most of the research measuring the electrophysiological effects 
of nicotine in humans and animals has been conducted in studies using 
cigarette smoking. Knott (in Remond, 1979) reported longer reaction 
times in subjects after smoking. There have been some studies that 
reported the effects of nicotine and tobacco smoking on skeletal 
muscle tone (Clark and Rand, 1968; Domino and Von Baugarten, 1969; 
Fagerstrom and Gotestam, 1977; and Webster, 1964). These studies 
report varying effects of smoking. In two of these studies (Clark and 
Rand, 1968; and Domino and Von Baumgarten, 1969) the patellar reflex 
was depressed by nicotine. Fagerstrom and Gotestam (1977) however, 
reported that the electromyographical activity of the trapezius 
muscle in the neck increased during tobacco smoking. Summarizing 
these studies, Domino (1979) states that 
.•• tobacco smoking of varying nicotine content has biphasic 
effects as far as electromyographic activity in concerned. 
Some skeletal muscles such as the trapezius show enhanced 
electromyographic activity while other muscles such as the 
quadriceps femoris show reduced electromyographic activity 
(p. 142). 
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These studies further seem to emphasize the recurring dual effects 
of nicotine at various sites in the body found by several 
investigators. 
Smokeless Tobacco Studies. In contrast to the large amount of 
literature existing on tobacco smoking studies, there exists very 
little research dealing with smokeless tobacco. This is probably 
a result of the obscurity of smokeless tobacco use within the past 
century. Most of the literature that does exist concerning smokeless 
tobacco involves surveys of smokeless tobacco use and the 
health-related risks associated with its use. An extensive amount of 
health-related literature seems to suggest a link between smokeless 
tobacco use and the increased incidence of oral cancers (Christen et 
al., 1979; McGuirt, 1983; Squires et al., 1984; Winn et al., 1981). A 
substantial amount of literature also exists that would not appear to 
confirm this relationship (Shklar et al., 1985; Smith et al., 1970; 
Smith, 1975), or suggest that smokeless tobacco may be a viable 
alternative to cigarette smoking (Kirkland, 1980; Russell et al., 
1980). 
Kozlowski (1984) reports that there is really no dispute that 
smokeless tobacco use presents fewer hazards to the user than the risks 
that are involved in smoking. Smokeless tobaccos expose the lungs 
to virtually no tobacco toxins, since no carbon monoxide or tar is 
produced. In addition, the oral cancers associated with smokeless 
tobacco are substantially less lethal and are more easily diagnosed 
than lung cancers (Kozlowski, 1984). This is a very controversial 
topic at this time and it is obvious that additional research is 
needed before the issue can firmly be resolved. 
Historical evidence seems to suggest that tobacco provides some 
satisfaction when it is taken as snuff or when held in the mouth and 
chewed (Russell, 1978). Nicotine is absorbed through the buccal 
mucosa during tobacco chewing. Russell and coworkers (1980) observed 
that a peak nicotine level is attained in the circulating blood in 5 
minutes or less with the use of snuff. It has also been reported that 
nicotine transfer from lip to brain can require less than 10 seconds 
(Jaffe, 1980). Any nicotine absorbed through the nasal or buccal 
mucosae gains access to the general circulation in the active form 
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before being metabolized in the liver, thereby delivering its effects 
quickly. Whereas inhaled powdered snuff and cigarette smoke produce a 
very rapid rise and subsequent fall in the plasma nicotine level 
(Russell, Jarvis, and Feyerabend, 1980), smokeless tobacco use produces 
a more gradual increase in the blood nicotine level as it attains 
similar peak concentrations (Gritz et al., 1981). Squires and 
associates (1984) suggest that the absorption of nicotine in its 
aqueous solution, when smokeless tobacco is used, should be similar to 
the absorption process involved in cigar smoking when the pH level is 
alkaline. 
Smokeless tobacco appears to produce the same cardiovascular 
effects of smoked tobacco and intravenously administered nicotine. 
Squires and associates (1984) found increases in heart rate and blood 
pressure in human subjects after using smokeless tobacco. A recent 
study corroborated these acute increased heart rate effects after 
smokeless tobacco use in a college-aged group of athletes and 
nonathletes (Edwards et al., 1985). 
A minimal amount of research exists that involves the 
electrophysiological effects of smokeless tobacco. The studies that 
do exist attempt to identify the effects of smokeless tobacco use on 
various simple motor tasks, including reaction and movement times, as 
well as total performance times. A recent study concluded that there 
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was no improvement in neuromuscular performance when reaction, 
movement, and performance times were measured after ingesting smokeless 
tobacco (Edwards et al., 1985). It was also suggested that the reason 
athletes may feel that their performances are improved while under the 
influence of smokeless tobacco may be attributable to the increased 
hemodynamic responses attained, which may lead to a psychological 
feeling of readiness (Edwards et al., 1985). In another study, it was 
concluded that reaction and performance times did not improve after 
ingestion of smokeless tobacco when using either a simple visual 
stimulus reaction time test or an ocular rotary pursuit test (Glover 
et al., 1984). It was also hypothesized that perhaps nicotine present 
at the neuromuscular junction assists acetylcholine in the neural 
transmission, thereby decreasing the reaction time component at this 
stage (Glover et al., 1984). 
Literature Related to Methodology 
Electromyography 
It has been known, at least since the middle of the nineteenth 
century, that the contraction of muscle tissue is accompanied by an 
electrical change. This electrical change has been called the muscle 
action potential, or map (deVries, 1980). Electromyography is the 
study of this electrical activity that is occurring in the muscle by 
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recording the muscle action potentials generated~ 
The practical use of this discovery had to await the invention of 
more sensitive instrumentation, as the early equipment was somewhat 
crude. The physiological aspects of electromyography were first 
investigated in Germany, in the early 1910's. English-speaking 
countries did not become involved in electromyography until after a 
publication by E.D. Adrian in 1925 (Rasch and Burke, 1978). This paper 
by Adrian (1925) reported that it was possible to determine the amount 
of activity occurring in human muscles during movement by using 
electromyography. 
The electromyograph probably represents one of the most 
significant developments in kinesiology as it has provided the means 
to study the neuromuscular mechanisms in great detail. 
Electromyography is used in many kinesiological research studies as 
well as in several clinical settings. In clinical settings, 
physicians, physical therapists, and other professionals may use 
electromyography to assist them in making diagnoses, as well as for 
making accurate prognosis and determination of appropriate 
treatment (Kraft, 1980). Much electromyographic instrumentation and 
procedures have been developed for the use of physicians in 
diagnosing abnormal neuromuscular function (deVries, 1980). 
In practice, the electromyographic instrumentation is a unique 
system designed as a whole, with considerable interrelation between 
circuit functions and with a number of common power supply and control 
circuits. In general, it contains some type of transducer (electrodes) 
connected to an amplifier system that amplifies the action potential 
so that it can be displayed on various types of display mediums, 
including cathode ray tubes, loudspeakers, and paper and fiber optic 
recorders. The electrodes represent the critical link in the 
electromyographic system. The choice of recording electrodes, 
their location relative to the anatomical structures being studied, 
and their state of cleanliness and repair have a large effect on the 
observed potentials. Recorded electromyographic potentials and 
applied electrical stimulations are obtained using metal needle and 
skin surface electrodes. These techniques impose different 
performance requirements on the electromyography system (Reiner and 
Rogoff, 1980). 
Needle electrodes are used when the activity of individual motor 
units or muscle fibers are studied. Most of the 434 skeletal muscles 
in the human body are accessible using needle electrodes (Johnson 
and Parker, 1980). 
Surface electrodes are used mainly when recording gross 
electromyographic activity and compound nerve and muscle potentials 
resulting from nerve stimulation, and are not useful when recording 
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the details of individual motor unit activity. A wide range of skin 
surface electrodes are available. Surface electrodes may be discs, or 
rectangular or strip forms, of various size, with the larger sizes used 
as ground electrodes. These electrodes are held in place with adhesive 
tape, straps, or double-sided adhesive discs. Bare metal electrode 
contact is made to the skin via electrically conductive electrode 
paste which reduces contact resistance, improves recording, and permits 
stimulation with less intensity, thus reducing the subject's 
discomfort, and reducing artifact. The skin surface should be 
cleaned to remove perspiration, which is electrically conductive, 
from the areas of recording and stimulation (Reiner and Rogoff, 1980). 
The muscle action potentials, when passing through the muscle 
tissue, fascia, subcutaneous fat, and skin, are severely decreased 
in magnitude (deVries, 1980). The ion movement which constitutes the 
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action potential is an electric current in the extracellular fluid that 
is volume conducted in three dimensions (Reiner and Rogoff, 1980). 
The equipment that is used in modern electromyography must be 
adjustable over a wide range of sensitivities and time scales and be 
capable of a number of modes of operation. The electrical potentials 
that may be of interest can range from millionths of a volt 
(microvolts) that are involved in sensory studies, up to thousandths 
(millivolts) of a volt encountered i.n some muscle action potential 
recording. In addition, the time resolution required can vary from 
seconds in gross electromyography studies, down to millionths of a 
second (microseconds) in single fiber electromyography (Reiner and 
Rogoff, 1980). The strength of contraction, and the appropriate 
instrumentation required, depends upon the nature of the investigation 
and is related to the number of motor units activated in motor 
studies (Scott, 1975). 
No activity is observed in normal muscle when at rest; 
however, action potentials are produced on contraction. These action 
potentials are summated from individual motor units asynchronously 
and result in a characteristic recording displayed on the cathode 
ray tube known as an interference pattern (Figure 4). When an 
individual fiber contracts, a wave of reversal of polarity passes along 
it and current flows first in one direction, then in the other 
(Figure 4). This produces the typical diphasic action potential on 
+ 
(A) INTERFERENCE PATTERN 
+ 
(B) DIPHASIC ACTION POTENTIAL 
Source: Herbert A. deVries, Physiology of Exercise for Physical 
Education and Athletics (1980). 
Figure 4. Electromyograph Recordings 
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the recorder (Scott, 1975). When electromygraphical investigations 
are conducted, the recordings are usually standardized so that 
downward deflections indicate positivity (Johnson and Parker, 1980). 
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Finally, Johnson and Parker (1980) note that when electromyography 
studies are performed, it is essential that the investigator have 
a thorough knowledge of functional anatomy, kinesiology, and surface 
anatomy. and suggest that an illustrated anatomic text be near the 
electromyograph. 
Nerve Conduction 
Reaction time has been recognized since the mid-nineteenth 
century as a potentialy powerful means of relating mental events to 
physical measures (Brebner and Welford, 1980). The time relationships 
involving the nerves and muscles can be measured using nerve conduction 
instrumentation. Stimulation of a motor nerve trunk elicits a 
contraction of the muscle which it supplies. The speed with which 
the nerve impulse travels can be assessed by measuring the interval 
of time that elapses between the application of the stimulus and the 
resulting action potential in the muscle (Scott, 1975). 
The use of motor nerve conduction studies is a relatively 
recent phenomenon, even though these studies are now routinely 
performed in clinical practice. The procedure is limited to those 
nerves which are accessible to stimulation, such as the median nerve 
in the arm (Goodgold and Eberstein, 1972). Procedures have been 
formulated for stimulating various other nerves within the body, 
including the ulnar and radial nerves in the upper extremity, and 
the peroneal, tibial, femoral, and sciatic nerves in the lower 
extremity (Braddom and Schuchmann. 1980). 
In clinical nerve conduction studies many nerve fibers are 
depolarized simultaneously, which results in a compound action 
potential; that is, the combined electrical effects of many action 
potentials from different nerve fibers is obtained (Melvin, 1980). 
The stimulation of large nerve trunks evokes nerve action potentials 
that are recordable mainly from the larger fibers, and the 
conduction velocity obtained represents the fastest conducting 
fibers of the mixed nerve (Braddom and Schuchmann, 1980). 
Nerve conduction velocity has also been demonstrated to be 
related to the intraneural temperature, with the velocity decreasing 
with decreasing temperature until approximately 8 centrigrade, when 
nerve function ceases (Abramson et al., 1966; Braddom and Schuchmann, 
1980). 
Nerve conduction velocity has not been found to vary 
significantly with increasing age. Normal adult values of nerve 
conduction velocity are usually reached by age 4. Braddom and 
Schuchmann (1980) report that these values remain relatively stable 
through age 60 before any decrease is observed. 
In motor nerve conduction studies there is a difference in the 
distal latency that is observed and that which would be predicted on 
the basis of the proximal nerve conduction velocity. This occurrence 
was discussed earlier in the introduction and is related to the fiber 
size and the time required to cross the neuromuscular junction. 
Normal distal latencies have been fairly well estabished for the 
median nerve (Table I). 
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Recording 
Distance 
7 em. 
8 em. 
TABLE I 
NORMAL VALUES OF MEDIAN NERVE DISTAL LATENCIES 
Mean 
Value 
3.3 msec. 
Std. 
Dev. 
3.7 msec. 0.3 msec. 
Range 
2.6-4.5 msec. 
Reference 
(1) 
(2) 
Source (1): William J. Shriber,~ Manual of Electrotherapy (1975). 
Source (2): Ernest W. Johnson, Practical Electromyography (1980). 
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Nerve conduction studies are usually performed using 
commerical electromyographical apparatus that incorporates built-in 
conduction equipment. This equipment requires the addition of a 
nerve stimulator to the standard electromyograph apparatus that is 
synchronized with the cathode ray tube display so that the sweep is 
triggered slightly before the stimulus is delivered to the subject. 
There are many types of stimulators available for use in conduction 
studies. Generally, there are two basic types: a surface bipolar 
stimulator that stimulates on top of the skin, and needle electrode 
stimulators (Braddom and Schuchmann, 1980). A current that changes 
suddenly in intensity has been found to be the most effective in 
producing a stimulus, rather than one which changes gradually; as 
a result, most stimulators provide a square wave stimulus (Scott, 
1975). Braddom and Schuchmann (1980) state that the nerve stimulator 
should be able to deliver a stimulus for a duration that can be varied 
between 0.1 millisecond, to at least 1.0 millisecond, and also have 
variable frequency selection ranging from 0.5 to 50 hertz. There 
is some disagreement regarding where the actual site of 
stimulation is occurring--the cathode, anode, or someplace 
between these two poles--when stimulating at the skin's surface. 
It is common practice to orient the bipolar stimulator so that the 
cathode is closest to the active recording electrode (Braddom and 
Schuchmann, 1980). 
Although most of the techniques for performing nerve conduction 
studies are relatively simple, the researcher must be aware of some 
potential sources of error that can lead to invalid results. There 
are specific sites in different regions of the body where normal 
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anatomical variations can and frequently do occur. An example of 
this occurrence in the forearm is a condition referred to as the 
Martin-Gruber anastomosis, where the median nerve sends fibers across 
to the ulnar nerve. This reportedly occurs 15 to 25% of the time 
in normal subjects (Braddom and Schuchmann, 1980). 
Cress and associates (1963) reported a relationship between hand 
dominance and the conduction velocity in the median and ulnar nerves, 
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with the velocity being slightly faster in the preferred arm. However, 
several other studies failed to find any relationship in hand dominance 
(Bhala and Goodgold, 1968; Currier and Nelson, 1974; LaFratta and 
Smith, 1964). 
Basmajian (1967) cautioned against making single clinical 
estimations of nerve conduction velocity in a brief period of time 
because of the normal diurnal rhythms observed in any individual. 
However, Wyrick and Duncan (1970) concluded that nerve conduction 
velocities obtained throughout the day within subjects will be 
consistent as long as the measures are obtained in a consistent manner 
and do not require more than 15 or 20 minutes. 
Electromyographic and nerve conduction equipment should be 
properly maintained and calibrated to minimize nerve conduction error 
due to equipment malfunctions. Probably the most common error is 
having the time scale miscalibrated (Braddom and Schuchmann, 1980). 
It is imperative that the technique used is standardized so that 
previous results can be compared with the current results. A 
standardized distance between the active recording electrode and the 
stimulator cathode should be used. Braddom and Schuchmann (1980) noted 
that the lengths of nerve segments in the median nerve below the elbow 
can be measured accurately with a calibrated tape. 
There is also some variation in reading the exact latency value 
from the recording obtained. Honet and associates (1968) reported 
an error of 4 to 5% due just to the variabiity of reading the latency 
values in these studies. Melvin and coworkers (1973) reported 
standard deviations of 0.3 milliseconds for the distal latencies 
in motor conduction using these techniques. 
Reversal of the stimulating cathode and anode can result in a 
prolonged distal latency value. The stimulus that is applied should 
always be supramaximal, otherwise some of the fastest conducting 
fibers may not be stimulated. This would result in a falsely 
prolongated latency value. However, if an extremely high supramaximal 
stimulus is used, the stimulus could be volume conducted to adjacent 
nerves and could also result in an erroneously short distal latency. 
These techniques must be considered when performing these studies 
(Braddom and Schuchmann, 1980). 
Finally. it should be obvious that for the safety of the subject 
and to facilitate interference-free studies, it is important to make 
sure that the equipment is plugged into a receptacle having a 
functioning ground. 
The investigator should also have a good knowledge of basic 
neurophysiology and neuropathology in order to accurately interpret 
the results of these studies. 
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CHAPTER III 
METHODOLOGY AND DESIGN 
Introduction 
The purpose of this chapter is to describe the research 
methodology that was employed in this study. Descriptions of the 
subjects, the research design, the variables, the instruments that 
were used for the collection of data, the procedures followed, and 
the method that was used for the statistical analysis of the data 
are presented. 
Subjects 
The sample for this study was selected from volunteer students 
that were enrolled in courses that were taught in the School of 
Health, Physical Education, and Leisure Studies at Oklahoma State 
University during the 1985 spring semester. Information and signup 
materials were distributed to all of the teachers in the department. 
Sample forms are included in Appendix A. A total of thirty-five 
students indicated an interest in participating in the study. Twenty 
subjects actually participated in the study. Two subjects were 
eliminated from the study since they did not complete all three of 
the treatment conditions used in the study. One additional subjects 
data was not used in the analysis because one of the pretreatment 
distal latency values in one of the treatment conditions was 
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abnormally long. Complete data was obtained for seventeen subjects, 
which comprised the final sample size. 
Subjects were allowed to schedule their testing periods throughout 
the day between the hours of 8:00 a.m. and 9:00 p.m. during the 1985 
spring semester. The actual testing period lasted approximately 30 to 
45 minutes. The subjects were required to abstain from any tobacco 
use during the two hours prior to each testing period. In addition, 
subjects were required to abstain from any strenuous physical activity 
involving the right arm during the two hours preceding each testing 
period. 
Each of the subjects received each treatment (placebo chewing 
gum, one pouch of Skoal Bandits, and the subject's regular "dip") 
during the study. Only two different brands of smokeless tobacco were 
used by the subjects in this study: Copenhagen and Skoal. Each 
subject received only one treatment in each testing session; 
therefore, each subject was required to complete three testing periods. 
The testing sessions were scheduled at least 24 hours apart. 
Research Design and Variables 
The research design that was utilized in this study to test the 
statistical hypotheses was the control-group time-series (repeated 
measures) design (Campbell and Stanley, 1963). This design was chosen 
because it was considered essential to obtain a pretreatment measure 
of distal latency in order to reliably evaluate the effects of the 
treatment. 
The fixed independent variables that were used in this study 
consisted of time and the separate treatments that were administered 
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to each subject. The three treatments administered to the subjects 
consisted of the following: 
1. Experimental til: One pouch of "Skoal Bandits" (United 
States Tobacco Company) smokeless tobacco. 
2. Experimental /12: The subject's regular brand and "dip" of 
smokeless tobacco, Copenhagen or Skoal (United States Tobacco 
Company). 
3. Control: One rolled-up stick of "Extra" (Wm. Wrigley Jr. 
Co.) chewing gum, without nicotine. 
The continuous dependent variable in this study formed a time 
construct of median nerve motor distal latencies. The sixteen levels 
of time forming the construct included one pretreatment distal latency 
and the distal latencies obtained after the treatment had been 
administered and was obtained for every minute from one minute through 
fifteen minutes. 
Instrumentation 
The NS6 nerve stimulator module, two AA6T electromyography/ 
biological amplifiers, and two PA63 preamplifiers of the TE42 
electromyography system (TECA Corporation) was used to measure the 
median nerve motor distal latencies. TECA paired surface electrodes 
were used to record the electromyographic potentials over the 
abductor pollicis brevis and flexor pollicis muscles of the right 
hand. A TECA bipolar stimulator electrode was used to stimulate the 
median nerve at the wrist of the right hand. The stimulator was 
synchronized with the cathode ray tube display so that the sweep was 
triggered slightly before the stimulus was delivered to the subject. 
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The distance between the active recording electrode and the wrist 
stimulation site was measured with a calibrated cloth tape to the 
nearest millimeter. 
The nerve stimulator provided a single, director pulse output of 
one pulse per second (~5%) for a duration of 0.1 millisecond (!5%). 
The stimulating voltages available were variable from 0 to 300 volts. 
The AA6T electromyography/biological amplifier utilized the PA63 
remote preamplifier at the end of an input cable, which provided 
minimal interference. The amplifier gain settings were variable from 
5 microvolts/centimeter to 10,000 microvolts/centimeters, and also 
provided three different pairs of frequency filter settings. The 
amplifier provided four internal calibration voltages. 
The TECA TE42 electromyography system utilized a cathode ray 
tube to display the potentials and a high speed direct recorder 
that copied the cathode ray tube display onto a fiber optic film 
recording. Sweep speeds that were available on the cathode ray tube 
display ranged from 0.5 to 500 milliseconds per division. The high 
speed recorder allowed recording speeds from 0.5 to 100 centimeters 
per second. 
Procedure 
All of the motor nerve distal latency testing was performed in the 
Human Performance Laboratory (room 126) of the Colvin Center at 
Oklahoma State University. The testing was conducted in a room that 
provided a constant environmental temperature. 
Preceding the first test session, each subject completed a human 
subjects consent form (Appendix B) and a questionnaire describing their 
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tobacco habits (Appendix C). After completing the forms in the first 
test session, the test period was initiated. After a pretreatment 
distal latency was obtained, the subject was administered a treatment. 
The subjects were allowed to expectorate the accumulated saliva into a 
container freely. The subjects were asked not to swallow the tobacco 
juice. Median nerve motor distal latencies were then recorded at each 
of the following posttreatment times: one minute through fifteen 
minutes, one per minute. Two additional test periods were then 
scheduled, during which the subject received the remaining two 
treatments. All of the subjects completed the three testing sessions 
at least 24 hours apart, and all subjects reported that they had 
adhered to the requirement of abstinence from tobacco use and strenuous 
activity prior to the testing sessions. All procedures were identical 
except for the treatments received. 
Since the literature failed to show any significant differences 
between distal latency values obtained involving handedness, all 
subjects used the right hand in all of the tests, which facilitated the 
experimental apparatus setup. The subject was in a seated position 
with the right arm extended and resting on a flat surface at shoulder 
level. The active recording electrode was placed one half the distance 
between the metacarpophalangeal joint of the thumb and the midpoint of 
the distal wrist crease (Figure 5). The reference electrode was placed 
distally on the thumb, and the ground electrode was placed over the 
dorsal side of the ulnar border of the hand. The nerve stimulation 
site was a distance of seven centimeters proximal to the active 
electrode in a location between the palmaris longus and flexor carpi 
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R 
S - Stimulator 
Ac - Active Electrode 
R - Reference Electrode 
G - Ground Electrode 
Source: Ernest W. Johnson, Practical Electromyography (1980). 
Figure 5. Electrode Placement and Stimulation Site 
49 
radialis tendons. This site was marked with a felt-tipped pen to 
facilitate accurate stimulating placements. 
The gain setting that was used on the amplifier was 5000 
microvolts/centimeter, with a low frequency filter setting of 2 hertz 
and a high filter setting of 10,000 hertz. The sweep speed that was 
used on the cathode ray tube was 2 milliseconds/centimeter. The optic 
recorder was set to the single-sweep superimposed mode, which recorded 
the trace on the cathode ray tube onto stationary paper. The paper was 
then advanced manually after each record was made. 
A calibration voltage of 1000 microvolts/centimeter was used at 
the beginning of each testing session. All distal latency measurements 
were obtained by slowly increasing the stimulator output voltage until 
the maximum amplitude response was obtained. The voltage was then 
increased an additional 25 to 50% to ensure a supramaximal stimulus. 
The stimulus voltages used in this study ranged from about 160 to 280 
volts. 
All responses were recorded on the fiber optic film, which was 
then used to calculate the distal latencies. The distal latencies were 
calculated by counting the time marks from the beginning of the sweep 
on the recording to the initial rise of the action potential recorded 
on the paper. Each small time mark on the recording represented a time 
interval of 0.1 milliseconds. A vertical line was drawn on the 
recording that coincided with the initial deflection of the action 
potential, and extended down into the time recording (Figure 6). A 
sample distal latency recording form that was used in the study is 
included in Appendix D. 
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-- 1.6 msec. --
Source: Ernest W. Johnson, Practical Electromyography (1980). 
Figure 6. Distal Latency Calculation. 
Slanted dotted lines represent 1 msec. 
After all the data had been obtained and analyzed, all participants 
in the study were contacted and provided a summary of the overall 
findings along with each subjects individual results by a letter 
(Appendix E). This letter also informed each subject that the chewing 
gum treatment that they had received in the study had been a placebo 
and did not contain any nicotine. 
Statistical Analysis 
The P2V package of the BMDP computer program on an IBM 30810 
computer system was used to analyze the data. This program allowed the 
median nerve motor distal latencies to be analyzed using an analysis of 
variance (ANOVA) with repeated measures. The .OS level of significance 
was used in testing the hypotheses. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
Characteristics of Subjects 
Seventeen volunteer subjects participated in this study, ranging 
in age from 18 to 32 years. Background information concerning each 
subject's tobacco habits was collected from the prestudy questionnaire 
(Appendix C) and is presented in Table II. The average period of time 
that the subjects reported using smokeless tobacco products was 6.3 
years, with a range from 2.5 years up to 12 years. Seven of the 
smokeless tobacco users in this study regularly used Copenhagen brand 
snuff, while the remaining ten subjects used regular Skoal. The 
subjects estimated the number of dips that they used each day, as well 
as estimated the size of the pinch they normally ingested. The general 
concensus showed that a medium-sized pinch was administered about six 
times per day by the subjects used in this study. An interesting 
observation surfaced from the prestudy questionnaire concerning when 
smokeless tobacco was used by the subjects. The majority of subjects 
reported using smokeless tobacco routinely after eating and when 
studying. Although this finding was incidental to this study, these 
behaviors were supported by similar findings in the review of the 
literature. 
All subjects reported that they had adhered to the requirement of 
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TABLE II 
CHARACTERISTICS OF SUBJECTS 
Subject Number 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Mean 
- - - - - - - - - - - --
Age 
(Years) 22 23 21 23 22 22 19 18 22 22 18 20 23 23 27 30 32 22.8 
Regular 
Tobacco Habit 
(C=Copenhagen C-7 
S:Skoal) c c c c c c s s s s s s s s s s c S-10 
Length of 
Habit 
(Years) 12 5 3.5 6 6 8 2.5 7 8 10 5 6 5 9 4 6 4 6.3 
Avg. Dips 
per Day 9 11 4 5 8 7 6 5 4 5 11 5 7 3 2 4 5 6 
Size of 
Pinch 
(S=Small 
M=Medium S-2 
L=Large) M L ~1 M L L M M s M L M s L M ~1 M M-10 
L-5 
\J1 
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abstinence from tobacco use and strenuous activity prior to the testing 
sessions. No subject reported any physical problems as a result of 
their participation in the study. All subjects seemed to adapt to any 
minor discomfort that may have occurred in the initial testing session. 
Data Analysis Results 
The raw data results area included in Appendix F. A repeated 
measures analysis of variance (ANOVA) was used to evaluate changes in 
the median nerve motor distal latency values over the duration of the 
investigation. The 3 X 16 repeated measures ANOVA included one within 
factor, condition, with three levels (chewing gum, Skoal Bandits, and 
regular dip), and another within factor, time, with sixteen levels (one 
pretreatment distal latency and fifteen posttreatment distal latencies, 
spaced one minute apart). The chewing gum level of the first factor 
provided a non-nicotine control situation. 
Table III presents the means and standard deviations of the distal 
latencies measured at each time for the tobacco usage groups and the 
treatments that they received. Table IV presents a summary of the 
repeated measures ANOVA analysis. 
A significant F (F = 1.72, p(O.OS) was found with the interaction 
between condition and time. A graph of the condition X time 
interaction (Figure 7) indicated that both nicotine conditions resulted 
in a slowing of the median nerve distal latencies. The graph of the 
non-nicotine chewing gum does not appear to follow this same pattern. 
A significant F (F = 8.59, p( 0.05) was also found for the main 
effect of time. Pair wise post hoc contrasts, using Tukey's HSD test, 
were performed comparing the mean of the pretreatment distal latency 
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Time 
PreTest 
1 Min Post 
2 Min Post 
3 Min Post 
4 Min Post 
5 Min Post 
6 Min Post 
7 Min Post 
8 Min Post 
9 Min Post 
10 Min Post 
11 fvlin Post 
12 Min Post 
13 Min Post 
14 Min Post 
15 Min Post 
TABLE III 
MEANS AND STANDARD DEVIATIONS OF THE MEDIAN 
NERVE MOTOR DISTAL LATENCIES (MSEC) 
Treatment Condition 
Gum "Bandits" 
N Mean SD Mean SD 
17 3.56 .433 3.66 .352 
17 3.56 .421 3.68 .366 
17 3.58 .421 3.68 .373 
17 3.56 .436 3.66 .367 
17 3.59 .403 3.69 .409 
17 3.59 .423 3.70 .384 
17 3.61 .426 3.70 .400 
17 3.58 .425 3.70 .391 
17 3.59 .427 3.71 .397 
17 3.59 .425 3.73 .410 
17 3.59 .407 3.75 .411 
17 3.58 .422 3.75 .403 
17 3.60 .409 3.75 .429 
17 3.57 .418 3.75 .421 
17 3.57 .403 3.75 .417 
17 3.59 .412 3.79 .412 
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Regular Habit 
Mean SD 
3.47 .291 
3.49 .333 
3.48 .319 
3.51 .309 
3.49 .324 
3.49 .331 
3.51 .315 
3.53 .324 
3.54 .343 
3.54 .324 
3.55 .312 
3.55 .354 
3.56 .308 
3.56 .312 
3.57 .326 
3.58 .354 
Source 
Condition 
Error 
Time (T) 
Error 
C X T 
Error 
TABLE IV 
REPEATED MEASURES ANOVA FOR THE MEDIAN NERVE 
MOTOR DISTAL LATENCY VALUES 
(C) 
Sum of 
Squares 
5.1914 
18.8928 
0.4935 
0.9190 
0.2157 
2.0068 
Degrees of 
Freedom 
2 
32 
15 
240 
30 
480 
Mean 
Square 
2.59570 
0.59040 
0.03290 
0.00380 
0.00719 
0.00418 
*Significant at the 0.05 level. 
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F Ratio 
4.40* 
8.59* 
1. 72* 
Distal 
Latency 
(msec.) 
3.79 
3.78 
3.77 
3.76 
3.75 
3.74 
3.73 
3.72 
3.71 
3.70 
3.69 
3.68 
3.67 
3.66 
3.65 
3.64 --
3.63 
3.62 
B _..-B/ 
B-B B~ --B-8............-
/ ~/ B 
/ B-B- /B s~s B -s 
-B = "Bandits" 
----G = Chewing Gum 
.• -.... R = Regular Habit 
3.61 -- ,.G 
,. ' 3.60 -- , ' G 
; ' ,. ' 3 59 -- G----G"' ' .. G----G----G.... ," ' G 
• I ' ,." ........ , \ " 3.58 -- _.G,, ,." G' 'G' ' ., .... "' .. R 
/ ; ' .; . 3.57 -- "' ', ,. G--·-G 
,. ' / 3.56 -- G----G' G ... ·R·· .... ·R·······R· 
3.55 --
3.54 --
3.53 
3.52 
3.51 
3.50 
3.49 -- .R· ... 
3.48 -- / .· -.R 
.R 
··R······ .. R· 
.. ·R······--R··· 
.. ·R··· .. ··R··· 
.. w· 
.R· 
3.47 ---R~-----------------------------------------------------------------------~-------
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (minutes) 
Figure 7. Condition X Time Interaction 
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with the mean of each of the 15 posttreatment distal latencies. Each 
treatment condition was tested using these contrasts. No significant 
differences were found for the time main effect in the chewing gum 
condition. In both the Skoal Bandits and the regular dip treatment 
conditions significant differences were found between the pretreatment 
distal latency and the 10, 11, 12, 13, 14 and 15 minute posttreatment 
distal latencies. 
A significant F (F = 4.40, p(0.05) was also found for the main 
effect of condition. Post hoc contrasts were also performed on this 
effect; however, no meaningful differences were obtained. 
Testing the Hypotheses 
A summary of the hypotheses tested, and the results for each is 
stated below: 
Hypothesis 1. 
There is no significant difference between the pretreatment 
median nerve motor distal latencies and the 15 posttreatment median 
nerve motor distal latencies of those subjects who ingest the placebo 
chewing gum. 
Post hoc comparisons, using the Tukey test, yielded no significant 
differences in any of the distal latencies after ingesting the chewing 
gum. The study failed to reject this null hypothesis. 
Hypothesis 2. 
There is no significant difference between the pretreatment median 
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nerve motor distal latencies and the 15 posttreatment median nerve 
motor distal latencies of those subjects who ingest one pouch of "Skoal 
Bandits" smokeless tobacco. 
Post hoc comparisons, using the Tukey test, found significant 
differences in the 10 through 15 minute posttreatment distal latencies 
when compared to the pretreatment distal latencies. The study rejected 
this hypothesis at the 0.05 level of significance. 
Hypothesis 3. 
There is no significant difference between the pretreatment median 
nerve motor distal latencies and the 15 posttreatment median nerve 
motor distal latencies of those subjects who ingest their regular 
smokeless tobacco dip. 
Post hoc comparisons, using the Tukey test, found significant 
differences in the 10 through 15 minute posttreatment distal latencies 
when compared to the pretreatment distal latencies. Therefore, this 
study also rejected this null hypothesis at the 0.05 level of 
significance. 
Hypothesis 4. 
There are no significant differences in the 15 posttreatment 
median nerve distal latencies of the subjects after receiving each of 
the three treatment conditions. 
The finding of a significant interaction between the treatment 
conditions and time resulted in this hypothesis also being rejected at 
the 0.05 level of significance. 
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In summary, this study attempted to identify the differences that 
resulted in a group of college-aged male smokeless tobacco users under 
two conditions of nicotine, and one placebo non-nicotine chewing 
gum control situation. Hypotheses 2. 3, and 4 were rejected at the 
0.05 level of significance, whereas this study failed to reject 
hypothesis 1 at the 0.05 level of significance. 
Discussion 
The findings of this investigation indicated that the action 
potential transmission is delayed as a result of smokeless tobacco 
ingestion, presumably as a result of the presence of nicotine at the 
neuromuscular junction. This finding does not support the hypothesis 
proposed by Glover and Associates (1984), and is, in fact, in 
opposition. No enhancement of the conducted impulse across the 
neuromuscular junction seemed to occur due to the presence of nicotine. 
This study supports the antagonistic role of nicotine (Kruk and Pycock, 
1979) by suggesting that nicotine present at the neuromuscular 
junction slows down the conducted impulses. Since the 
nicotine-receptor combination has been found to be longer lasting than 
the acetylcholine-receptor combination (Ashton and Stepney, 1982), 
perhaps this slowing is the result of the nicotine-receptor 
combinations at the neuromuscular junction that selectively block some 
of the faster conducting nerve fibers. 
This study also supported the expected research hypotheses of the 
investigator. It was anticipated that there would be a slowing of the 
distal latency values once nicotine reached the neuromuscular junction, 
due to nicotine's blocking action. No effect was expected following 
61 
ingestion of the nicotine-free chewing gum. Nervous transmission at 
the neuromuscular junction was not expected to improve when nicotine 
was initially administered. If any facilitation did occur with the 
initial administration of nicotine at the neuromuscular junction, it 
probably would not have been observed using the techniques in this 
study, since the stimulation impulse was applied by an external 
stimulus. 
The apparent absorption rate of nicotine in this study agreed with 
earlier studies (Gritz et al., 1981; Russell et al., 1980) that found 
peak nicotine levels in the blood after about 5 minutes with the use of 
snuff. Gritz and associates (1981) reported a gradual increase in the 
blood nicotine level with the use of smokeless tobacco. Examination of 
the graphs of the means during the two nicotine treatment conditions 
(Figure 7) indicated that the distal latencies were gradually beginning 
to slow after about 5 minutes. Statistical significance between the 
pretreatment distal latency and the posttreatment distal latencies did 
not occur until the 10 minute posttreatment time period; however, 
both graphs show the gradual slowing, which suggests that there was a 
gradual increase in the amount of nicotine present at the neuromuscular 
junction. 
Another interesting finding was the variation in the pretreatment 
distal latencies among the three treatment conditions. Since these 
differences were not statistically significant, however, they probably 
represent normal variabilities in nerve conduction and distal latency 
studies. It was noted earlier (Table I) that normal variations in the 
median nerve distal latencies can range from 2.6 to 4.5 milliseconds. 
62 
Another possible explanation of the variations that occurred in these 
measures might be attributed to the subjects tobacco use before each 
testing period. Although the order of treatments received was 
counterbalanced, the subjects were aware of what treatment condition 
they were going to receive in each session. This may have influenced 
their tobacco habits in the time period immediately before the two hour 
abstinence period prior to the scheduled test. Subjects may have 
abstained from their regular tobacco habit for a longer period of time 
before the two hour abstinence period on that test day, since they knew 
that they would be receiving a dip of their regular habit on that day. 
In followup studies, a longer abstinence period than the two hours used 
in this study should be considered. 
Although significance was found in the interaction and both main 
effects, caution must be observed in interpretation. Strength of 
association measures were.calculated (ltt) for each of these effects. 
Roughly 19% of the variance in the distal latency measures in this 
san1ple was accounted for by the treatment condition, which is 
relatively strong. However, the strength of association for the time 
and interaction effects, 1.8% and 0.8% respectively, are very weak. 
Even though the main effects and interaction were statistically 
significant, they may not represent practical significance. A slowing 
of the impulse by one-tenth of a millisecond may not be of too much 
concern to tobacco users to alter their habit. However, when one 
considers the complexity of the nervous system and the importance of 
acetylcholine as a neurotranmitter in many synapses, the results could 
take on added importance. This study evaluated the effects only at the 
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neuromuscular junction in the right thumb. This mechanism is likely 
occurring and influencing several other links in the conduction system 
of the human body. 
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CHAPTER V 
CONCLUSIONS AND RECOMMENDATIONS 
The major conclusion that can be made from this study is that the 
distal latency recorded in the median nerve at the wrist is slowed as 
the result of smokeless tobacco ingestion. This slowing did not seem 
to be related to the dosages administered in this study. as similar 
changes were observed in both tobacco conditions. Perhaps some minimal 
required dose was obtained in the treatments used in this study that 
sufficed to produce the observed effects. 
In addition. the non-nicotine chewing gum did not appear to follow 
the same trend as the two tobacco treatment conditions, even though 
this was not able to be statistically demonstrated. 
From the research studies that were reviewed for this study, it 
seems obvious that the actions of nicotine are complex. It is further 
concluded that not enough research has been completed to help answer 
many of the perplexing questions that exist. 
The relationship that seems to exist between tobacco use and 
eating was identified in the literature review and also surfaced in the 
responses obtained on the prestudy questionnaire. This would be an 
interesting area for additional research. There also appears to be 
some type of relationship that is behaviorally related to why people 
use smokeless tobacco. This is also an area that deserves additional 
research. 
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It is recommended that this study be replicated with a larger 
sample size. Although the minimal sample size was obtained for this 
study, additional subjects may provide a more powerful test of these 
hypotheses. A mixed model design could be employed with a larger 
sample size, thereby allowing the investigator to randomly assign 
subjects to different treatment conditions. This could facilitate the 
recruitment of subjects since the subject would only have to complete 
one testing session. Perhaps the variance between the pretreatment 
distal latencies observed in this study would be decreased. In 
addition, the distal latency values could be observed beyond the 15 
minute posttreatment times that were used in this study. Other 
nerve-muscle junctions in the body could also be readily observed using 
these techniques. 
It is recommended that this study be replicated with a more 
quantified dosage of nicotine administered to the subjects. Although 
the "Skoal Bandits" condition used in this study was somewhat 
standardized, the regular habits of the subjects may have varied 
considerably since two brands of smokeless tobacco (Copenhagen and 
Regular Skoal) were used by the subjects. A study using nicotine-free 
and nicotine gum could be used to obtain this quantification. 
Another recommendation for follow up studies of this nature 
involves the element of control. It is recommended that the subjects 
that participate in any future studies be carefully screened in regards 
to their usage of other drugs such as alcohol or marijuana. These 
factors were not involved in this study and should probably be 
considered. Two additional factors that should also be considered 
include the time of day the subjects are tested and the subjects 
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previous activity and sleep levels. More control might be obtained by 
addressing these factors in future studies. 
Finally, these smokeless tobacco and nicotine studies could and 
should be extended to sensory and motor nerve conduction velocity 
investigations in order to observe the effects of nicotine in other 
areas of the human nervous system. It would be interesting to observe 
if the results of these future studies would parallel the results that 
were obtained in this investigation. 
It is somewhat disconcerting to read about the growing number of 
smokeless tobacco users in this country, especially among our young 
children, who are using these products without a great deal of 
knowledge concerning the acu,te and chronic effects of smokeless tobacco 
products on the human body. The scientific community must rapidly rise 
to the challenge of discovering the full effects of smokeless tobacco 
use on the human body. 
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NERVE CONDUCTION-SMOKELESS TOBACCO STUDY 
Dear Instructor: 
I am currently involved in the process of identifying and selecting 
subjects for my doctoral research. My research seeks to measure the 
electrophysiological effects of smokeless tobacco on the nerve-muscle 
junction in the median nerve of the arm. 
I would appreciate your assistance in identifying possible subjects 
for my study. I would ask that you make a brief announcement to your 
class concerning the following information and pass around the signup 
sheet included, and then return it to me as soon as possible. 
I am especially interested in identifying subjects currently 
using smokeless tobacco and who would be interested in participating 
in this study. I plan to randomly select from those subjects indicating 
an interest to participate, so there is a possibility of a subject not 
being selected to participate in the study. 
Those subjects that are selected for the study will be required to 
complete three (3) testing sessions, each of which will last 
approximately 30 minutes. In each session the subjects finger muscles 
will be electrically stimulated and an electromyograph recording made. 
The entire procedure will be more fully explained to those subjects 
wishing to participate in the study. 
Please instruct those students who are interested in participating 
to sign the enclosed form and indicate a phone number where they may be 
contacted. If any student wishes additional information before 
committing to the study, please have them indicate on the form or have 
them stop by my office (room 126) for additional information. 
Thank you for your time and assistance in this matter. I greatly 
appreciate your help! 
Sincerely, 
Mike lester 
NERVE CONDUCTION - SMOKELESS TOBACCO STUDY 
SIGN-UP SHEET 
Please list name, phone number, and tobacco use below if you are 
interested in participating in the study. 
NAME PHONE NO. DO YOU USE SMOKELESS TOBACCO 
1. ----------------
2. 
----------------
3. 
-----------------
4. ----------------
5. ----------------
6. ----------------
7. 
----------------
8. ----------------
9. ----------------
10. ---------------
11. ----------------
12. ----------------
13. 
----------------
14. 
----------------
15. 
----------------
16. ----------------
17. 
----------------
18. ----------------
19. 
----------------
20. 
----------------
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Protection of Human Subjects Consent Form 
Subject's Name: Date: ----
Project Title: The Effects of Smokeless Tobacco Ingestion on the Motor 
Distal Latency of the Median Nerve 
Explanation of the procedure to be undertaken: 
Each subject will be asked to complete a written prestudy 
questionnaire. Each subject will be required to complete three (3) 
separate testing sessions. Each subject will receive a different 
treatment in each session. The subject will be required to abstain 
from any tobacco or strenuous physical activity during the two (2) 
hours preceding each testing session. After reporting to the Human 
Performance Lab (Colvin Center, room 126) the subject will be 
prepared for the EMG/nerve conduction procedures by having three (3) 
surface electrodes placed on the right hand. The median nerve will 
then be stimulated at the wrist with the nerve stimulator so that a 
pretreatment recording can be obtained. The subject will then 
receive one (1) of the following treatments: 1) one pouch of 
"Skoal Bandits" smokeless tobacco, 2) the subjects regular dip, 
or 3) one piece of nicotine substitute chewing gum. One minute 
after the treatment is received the median nerve will again be 
stimulated at the wrist and a recording made. This procedure will 
continue each succeeding minute for a period of fifteen (15) minutes. 
The subject will be allowed to expectorate at will into a cup that 
will be provided. The first testing period will last approximately 
forty-five (45) minutes. The second and third testing periods will 
last approximately thirty (30) minutes each. The total time 
required for each subject in the study will be approximately two (2) 
hours. Each testing session will be scheduled at least twenty-four 
(24) hours apart. 
Explanation of attendant discomforts and risks to be expected: 
In this experiment each subject will have the muscles of the 
right thumb electrically stimulated with the stimulator electrode 
by the investigator, Mike Lester. Mike Lester has performed these 
procedures in earlier investigations and is competent in the nerve 
conduction technique. The subject may experience some discomfort 
in the initial stimulation process. Although the procedure may 
result in some minor discomfort, it will not result in any physical 
damage to the nerve-muscle mechanism. These procedures are 
routinely performed in clinical settings. 
Explanation of benefits to be expected: 
The benefits of this project include the opportunity for the 
subject to become acquainted with experimental procedure as well as 
the possibility of obtaining additional information on smokeless 
tobacco effects on the body. In addition, some subjects may receive 
"bonus points" in a course being taught in the HPELS department by 
participating in this investigation. 
Explanation of confidentiality: 
80 
The subject is free to deny answering any question on the prestudy 
questionnaire. No subject's name or responses to any of the questions 
on the prestudy questionnaire will be accessible to anyone except the 
investigator, Mike Lester. Each subjects results will be coded with a 
number and no names will be used when the results are reported. 
I have fully explained to the Subject the 
nature and purposes of the procedures described above and such risks as 
are involved in its performance. I have asked the Subject if any 
questions have arisen regarding the procedures and have answered these 
questions to the best of my ability. 
Investigator's Signature 
I have been fully informed of the above noted procedure with its 
possible benefits, risks, and consequences. I hereby agree to become 
a subject in this investigation. I understand that if physical, 
psychological, or other injury should occur as a direct result of this 
activity, neither compensation nor long-term treatment will be 
provided. Furthermore, I recognize that I am free to withdraw this 
consent and to discontinue participation in this project and activity 
at any time without prejudice to me. 
Subject's Signature 
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PRE-STUDY QUESTIONNAIRE 
(SMOKELESS TOBACCO USERS) 
Name: Date: 
Sex: M F Birthdate: Age: 
----
1. Are you involved in any organized sport? y N 
If yes, what sport: 
2. What brand of smokeless tobacco do you regularly use? 
3. How often do you regularly use smokeless tobacco? 
a. Number of "dips" per day: 
b. How Long (number of days) does one can of smokeless 
tobacco usually last you? 
c. What size of "pinch" or "dip" would you classify as your 
usual dose? 
__ small pinch __ medium pinch __ large pinch 
4. What do you usually do with the tobacco juice produced? 
------ always expectorate (spit out) 
____ usually expectorate; occasionally will swallow juice 
____ usually swallow juice 
5. Are there specific times during the day when you normally use 
smokeless tobacco? y N 
If yes, when? (describe circumstances): 
82 
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6. How long have you used smokeless tobacco? 
less than 6 months 
between 6 months and 1 year 
____ longer than 1 year 
If you have used smokeless tobacco for more than 1 year, estimate 
how long you have used it: 
----------------------------------------
7. Do you currently use any other forms of tobacco? y N 
If yes, what type and how often? 
chewing tobacco (leaf or plug) How often used: 
__ cigar How often used: 
cigarette How often used: 
___ pipe How often used: 
other: How often used: 
If no, have you used any other form of tobacco products regularly in 
the past, and for what length of time? 
chewing tobacco (leaf or plug) How often used: 
cigar How often used: 
cigartte How often used: 
__ pipe How often used: 
other: How often used: 
8. Have you ever used Skoal Bandits smokeless tobacco regularly in the 
past? y N 
If yes, do you still use it regularly? y N 
9. Briefly describe why you use smokeless tobacco: 
APPENDIX D 
DISTAL LATENCY RECORDING FORM 
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DISTAL LATENCY RECORDING FORM 
Name: Date: 
--------------------------------- ------------------------
Treatment Received: 
-------------------------------------------------
------- Subject has abstained from tobacco use for previous 2 hours. 
-------
Subject has abstained from strenuous physical activity for 
previous 2 hours. 
Completed Measure Calculated Value (msec) 
PreTreatment Distal Latency 
Treatment Administered 
1 minute posttreatment DL 
2 minute posttreatment DL 
3 minute posttreatment DL 
4 minute posttreatment DL 
5 minute posttreatment DL 
6 minute posttreatment DL 
7 minute posttreatment DL 
8 minute posttreatment DL 
9 minute posttreatment DL 
10 minute posttreatment DL 
11 minute posttreatment DL 
12 minute posttreatment DL 
13 minute posttreatment DL 
14 minute posttreatment DL 
15 minute posttreatment DL 
APPENDIX E 
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(Study Participant's Name) 
(Street Address) 
(City, State Zip) 
Dear (Participant's Name), 
Mike Lester 
School of HPELS 
Oklahoma State Univ. 
Stillwater, OK 74078 
June 16, 1985 
Well I finally finished analyzing all of the data for the 
smokeless tobacco nerve conduction velocity experiment that you 
participated in! Your individual results appear on a separate sheet 
along with the overall results of all of the other participants. 
Good thing that the computer was invented! I would not have wanted 
to do all of the statistical calculations by hand ••• I'd still be 
doing them! 
First off though, I need to inform you that the chewing gum 
treatment that you received in the study did NOT contain any 
nicotine! It was just plain old Wrigley's "Extra" spearmint 
flavored chewing gum. You were told that it contained nicotine so 
that you "thought" you were still receiving some nicotine. Thus, 
this treatment condition served as my "control" situation. Sorry 
about that! 
I have enclosed a copy of the abstract from my study, which 
outlines the major results. Your results are listed on the sheet 
listing the group scores in each of the treatment conditions. In 
general, the overall effect of the two nicotine conditions seemed to 
slow the conduction speed by about 0.1 millisecond!! You can 
compare your own results to the averages, as a couple subjects 
actually increased slightly! 
I would like to thank you for participating in this study 
and if you should ever have any other questions concerning it you 
can contact me around the Colvin Center. Thanks again and have a 
good summer! 
Sincerely, 
Mike Lester 
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Results of all participants: 
Treatment 
Condition 
Pre-
Treat. 
1 2 
Post-Treatment 
3 4 5 6 7 8 9 10 11 12 13 14 15 
Chewing Gum 3.56 3.56 3.58 3.56 3.59 3.59 3.61 3.58 3.59 3.59 3.59 3.58 3.60 3.57 3.57 3.59 
"Bandits" 3.66 3.68 3.68 3.66 3.69 3.70 3.70 3.70 3.71 3.73 3.75 3.75 3.75 3.75 3.75 3.79 
Reg. Habit 3.47 3.49 3.48 3.51 3.49 3.49 3.51 3.53 3.54 3.54 3.55 3.55 3.56 3.56 3.57 3.58 
Your Results: 
Gum 
Bandits 
Reg. Habit 
Note: The values in the table are the median nerve motor distal latencies obtained. 
Units are milliseconds (msec.). 
co 
cc 
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Name: Michael Joseph Lester Date of Degree: July, 1985 
Institution: Oklahoma State University location: Stillwater, Oklahoma 
Title of Study: THE EFFECT OF SMOKELESS TOBACCO INGESTION ON THE MOTOR 
DISTAL LATENCY OF THE MEDIAN NERVE 
Pages in Study: 95 Candidate for Degree of Doctor of Education 
Major Field: Higher Education 
Scope of Study: The purpose of the study was to determine the effects 
of smokeless tobacco ingestion on the median nerve motor distal 
latencies in a group of subjects who regularly used smokeless tobacco 
products. Specifically, the nervous transmission at the neuromuscular 
junction in the right thumb was compared before and after the subjects 
were administered three treatment conditions. Two of the treatments 
contained nicotine (one pouch of ''Skoal Bandits" and a pinch of the 
subjects regular tobacco habit--- Copenhagen or Regular Skoal), while 
the third treatment consisted of a non-nicotine chewing gum. 
Median nerve distal latencies were obtained, using electromyographic 
and nerve conduction instrumentation, before the treatment was 
administered to the subject, and once every minute for 15 minutes 
after the treatment was administered. 
The population of the study consisted of seventeen volunteer subjects 
between the ages of 18 and 32 years. All subjects were males. All 
subjects received all three of the treatment conditions, spaced at 
least 24 hours apart. 
Findings and Conclusions: Significant differences were obtained among 
the three treatment conditions over time. The distal latencies 
observed during the two nicotine treatment conditions gradually 
increased during the posttreatment time periods. The distal latencies 
in the non-nicotine treatment condition did not follow this same 
trend. 
It was concluded that smokeless tobacco ingestion resulted in a delay 
in the nervous transmission across the neuromuscular junction. This 
delay was hypothesized to be caused by the enduring binding action 
of nicotine to the acetylcholine receptor sites, thereby effectively 
blocking the impulse in some of the faster conducting nerve fibers in 
the neuromuscular junction. 
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Subject Treatment 
Condition 
Pre-
Treat. 
1 Chewing Gum 2.9 
"Bandits" 3.5 
Reg. Habit 3.2 
2 Chewing Gum 3.3 
"Bandits" 3.6 
Reg. Habit 3.6 
3 Chewing Gum 3.4 
"Bandits" 3.4 
Reg. Habit 3.5 
4 Chewing Gum 4.3 
"Bandits" 4.0 
Reg. Habit 3.9 
ACTUAL TEST SCORES (Times in Table are in milliseconds) 
Post-Treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
2.9 2.9 2.9 3.0 3.0 3.0 3.0 2.9 3.0 3.0 2.9 3.0 2.9 2.9 2.9 
3.5 3.5 3.5 3.5 3.6 3.5 3.5 3.6 3.5 3.6 3.5 3.5 3.6 3.7 3.7 
3.1 3.1 3.1 3.0 3.0 3.0 3.0 3.0 3.1 3.1 3.0 3.1 3.1 3.1 3.1 
3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 
3.7 3.6 3.6 3.6 3.5 3.7 3.6 3.6 3.7 3.6 3.6 3.6 3.7 3.6 3.7 
3.5 3.5 3.6 3.6 3.6 3.6 3.7 3.7 3.6 3.7 3.7 3.7 3.7 3.7 3.7 
3.4 3.3 3.3 3.3 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 
3.4 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 
3.5 3.5 3.5 3.4 3.5 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 
4.4 4.3 4.3 4.3 4.3 4.3 4.3 4.3 4.3 4.2 4.3 4.3 4.3 4.2 4.2 
4.2 4.2 4.2 4.2 4.2 4.2 4.0 4.0 4.2 4.2 4.1 4.3 4.2 4.2 4.3 
4.0 3.9 3.9 3.9 3.8 3.8 3.8 3.9 3.9 3.9 3.9 3.9 3.9 4.0 4.0 
\.0 
1--' 
Subject Treatment 
Condition 
Pre-
Treat. 
5 Chewing Gum 3.4 
"Bandits" 3.5 
Reg. Habit 3.6 
6 Chewing Gum 3.2 
"Bandits" 3.4 
Reg. Habit 3.3 
7 Chewing Gum 3.4 
"Bandits" 3.7 
Reg. Habit 3.1 
8 Chewing Gum 4.1 
"Bandits" 4.0 
Reg. Habit 3.8 
ACTUAL TEST SCORES (Times in Table are in milliseconds) 
Post-Treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
3.4 3.5 3.4 3.4 3.5 3.5 3.4 3.4 3.5 3.5 3.5 3.5 3.4 3.4 3.4 
3.5 3.5 3.4 3.5 3.4 3.4 3.4 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 
3.7 3.7 3.7 3.7 3.8 3.8 3.8 3.8 3.8 3.8 3.9 3.9 3.9 3.9 4.0 
3.2 3.2 3.2 3.3 3.3 3.3 3.2 3.2 3.2 3.2 3.3 3.3 3.3 3.3 3.3 
3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.3 3.3 3.4 3.4 3.4 3.4 3.4 3.4 
3.3 3.2 3.3 3.3 3.3 3.4 3.4 3.3 3.3 3.4 3.3 3.4 3.3 3.4 3.3 
3.4 3.5 3.4 3.4 3.4 3.5 3.4 3.4 3.5 3.5 3.4 3.4 3.4 3.4 3.5 
3.7 3.6 3.7 3.7 3.8 3.8 3.9 3.9 3.8 3.8 4.0 3.8 3.8 3.8 3.9 
3.0 3.0 3.1 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.1 3.0 3.1 3.0 3.0 
4.0 3.9 3.9 3.9 3.9 3.9 3.7 3.9 3.8 3.8 3.9 3.9 3.8 3.8 3.8 
4.0 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 4.0 4.0 4.0 4.0 4.1 
4.0 4.0 4.0 4.0 4.0 3.9 3.9 3.9 4.0 4.0 4.0 3.9 3.9 3.9 4.0 
\!) 
N 
Subject 
9 
10 
11 
12 
Treatment 
Condition 
Chewing Gum 
"Bandits" 
Reg. Habit 
Chewing Gum 
"Bandits" 
Reg. Habit 
Chewing Gum 
"Bandits" 
Reg. Habit 
Chewing Gum 
"Bandits" 
Reg. Habit 
Pre-
Treat. 
3.3 
3.4 
3.5 
4.0 
3.9 
3.9 
3.7 
4.3 
3.6 
3.3 
3.3 
3.3 
ACTUAL TEST SCORES (Times in Table are in milliseconds) 
1 2 3 4 5 
3.4 3.4 3.4 3.4 3.3 
3.4 3.5 3.4 3.4 3.5 
3.6 3.6 3.5 3.5 3.6 
-4.0 4.1 4.1 4.1 4.1 
3.9 3.9 3.9 4.1 4.1 
3.7 3.7 3.7 3.8 3.8 
3.8 3.8 3.8 3.8 3.9 
4.4 4.5 4.4 4.6 4.5 
3.8 3.7 3.8 3.7 3.7 
3.3 3.3 3.3 3.4 3.3 
3.4 3.3 3.3 3.3 3.3 
3.3 3.3 3.3 3.3 3.3 
Post-Treatment 
6 7 8 
3.4 3.4 3.4 
3.4 3.5 3.5 
3.6 3.7 3.8 
4.2 4.2 4.2 
4.1 4.1 4.3 
3.8 3.9 3.8 
3.8 3.8 3.9 
4.5 4.5 4.4 
3.8 3.8 3.8 
3.3 3.3 3.4 
3.4 3.3 3.3 
3.3 3.3 3.3 
9 10 11 
3.3 3.3 3.4 
3.5 3.5 3.5 
3.7 3.7 3.7 
4.2 4.2 4.2 
4.3 4.2 4.3 
3.8 3.8 3.7 
3.9 3.9 3.9 
4.5 4.6 4.5 
3.8 3.8 4.0 
3.3 3.3 3.3 
3.3 3.3 3.3 
3.4 3.4 3.3 
12 13 
3.4 3.3 
3.5 3.5 
3.7 3.7 
4.2 4.2 
4.3 4.3 
3.8 3.8 
4.0 3.8 
4.5 4.5 
3.7 3.8 
3.3 3.3 
3.3 3.4 
3.4 3.4 
14 
3.4 
3.5 
3.8 
4.2 
4.3 
3.8 
3.8 
4.5 
3.8 
3.4 
3.3 
3.4 
15 
3.4 
3.5 
3.8 
4.2 
4.3 
3.9 
3.9 
4.5 
3.8 
3.4 
3.4 
3.4 
\.0 
VJ 
Subject Treatment Pre-
Condition Treat. 
13 Chewing Gum 4.3 
"Bandits" 4.1 
Reg. Habit 3.8 
14 Chewing Gum 4.0 
"Bandits" 4.2 
Reg. Habit 3.5 
15 Chewing Gum 3.7 
"Bandits" 3.3 
Reg. Habit 3.0 
16 Chewing Gum 3.2 
"Bandits" 3.4 
Reg. Habit 3.4 
ACTUAL TEST SCORES (Times in Table are in milliseconds) 
Post-Treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
4.3 4.3 4.3 4.3 4.3 4.4 4.3 4.3 4.3 4.3 4.2 4.2 4.2 4.2 4.2 
4.0 4.0 4.0 4.0 4.0 4.1 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 
3.8 3.8 3.8 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 
4.0 4.0 4.1 4.0 4.1 4.0 4.1 4.0 4.0 4.0 4.0 4.0 4.1 4.1 4.2 
4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.3 4.2 4.3 4.3 4.3 4.3 
3.6 3.7 3.7 3.6 3.6 3.6 3.7 3.8 3.8 3.7 3.8 3.8 3.8 3.8 3.8 
3.4 3.6 3.6 3.6 3.6 3.6 3.6 3.5 3.5 3.5 3.5 3.5 3.5 3.4 3.5 
3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.4 3.4 3.5 3.5 3.5 3.5 3.5 3.5 
3.0 3.1 3.0 3.1 3.0 3.1 3.1 3.0 3.1 3.1 3.0 3.1 3.1 3.1 3.1 
3.3 3.3 3.2 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 
3.4 3.4 3.4 3.4 3.5 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 3.4 
3.4 3.4 3.5 3.4 3.4 3.5 3.4 3.5 3.4 3.4 3.4 3.5 3.5 3.4 3.4 
\!) 
.p. 
Subject Treatment 
Condition 
Pre-
Treat. 
17 Chewing Gum 3.1 
"Bandits" 3.2 
Reg. Habit 3.0 
18 Chewing Gum 5.4 
"Bandits" 4.4 
Reg. Habit 4.3 
ACTUAL TEST SCORES (Times in Table are in milliseconds) 
Post-Treatment 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
3.1 3.1 3.1 3.1 3.0 3.0 3.0 3.1 3.0 3.1 3.0 3.1 3.1 3.1 3.1 
3.2 3.2 3.2 3.1 3.2 3.1 3.2 3.1 3.2 3.2 3.2 3.1 3.0 3.1 3.2 
3.0 3.0 3.1 3.1 3.1 3.1 3.2 3.2 3.2 3.3 3.2 3.3 3.2 3.3 3.2 
5.3 5.3 5.4 5.4 5.3 5.4 5.4 5.4 5.4 5.4 5.4 5.5 5.6 5.5 5.5 
4.4 4.3 4.4 4.4 4.4 4.4 4.5 4.5 4.5 4.5 4.6 4.5 4.5 4.6 4.6 
4.3 4.3 4.4 4.3 4.4 4.7 4.7 4.7 4.7 4.8 4.8 4.8 4.8 4.8 4.8 
NOTE: Data for subject H 18 was not used in the analysis. 
'-0 
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